ResMed | RMD - Pre Tax Profit



ResMed reported $479.87M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Ansell USD 107M 39.1M Jun/2024
AtriCure USD -5929000 579K Jun/2025
Baxter International USD -3000000 286M Mar/2025
Cochlear AUD 254.2M 6.2M Jun/2024
Cooper Companies USD 151.9M 7.4M Jul/2025
CSL USD 2.54B 1.34B Dec/2024
Dexcom USD 241.1M 86.8M Jun/2025
Edwards Lifesciences USD 400.2M 33.7M Jun/2025
Fisher Paykel Healthcare NZD 148.45M 57.95M Mar/2025
Globus Medical USD 188.17M 84.5M Jun/2025
Haemonetics USD 45.17M 25.57M Jun/2025
Hologic USD 235M 263.5M Jun/2025
Idexx Laboratories USD 362.35M 52.27M Jun/2025
Insulet USD 28.4M 19.7M Jun/2025
Integra LifeSciences USD -530952000 500.92M Jun/2025
Intuitive Surgical USD 832.1M 163.6M Jun/2025
Masimo USD 55.4M 13M Jun/2025
Medtronic USD 1.87B 612M Jul/2025
Philips EUR 337M 28M Jun/2025
Ramsay Health Care AUD 240.1M 24.6M Jun/2024
ResMed USD 479.87M 62.17M Jun/2025
Sigma Healthcare AUD 8.15M 7.4M Jul/2024
Sonic Healthcare AUD 348.85M 133.56M Dec/2024
Steris USD 231.9M 122.1M Jun/2025
Teleflex USD 135.25M 26.3M Jun/2025
Thermo Fisher Scientific USD 1.62B 1.01B Mar/2025